J Infect Dis. 1991 Jun;163(6):1279-85.

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK.

Source

Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303.

Abstract

The fluoroquinolones, particularly ciprofloxacin, have been suggested to treat methicillin-resistant Staphylococcus aureus (MRSA) infections and colonization and methicillin-susceptible S. aureus (MSSA) infections. The development of ciprofloxacin resistance in MRSA and MSSA was prospectively evaluated. After 3 months of ciprofloxacin use, high-level resistance (MIC90, 64 micrograms/ml) developed in MRSA and increased at an alarming rate, from none to 79% over a 1-year period. High-level ciprofloxacin resistance also developed in MSSA, increasing to 13.6% over the same period. Antibiograms, phage typing, and plasmid profile analysis suggest that more than one clone of MRSA developed resistance and that ciprofloxacin resistance is not associated with the acquisition of a new plasmid. Most patients had nosocomial acquisition and about one-half had a history of previous ciprofloxacin use. Ciprofloxacin resistance can develop rapidly in S. aureus; thus, ciprofloxacin appears to have limited usefulness in treating staphylococcal infections and colonization, especially those due to MRSA.

PMID:: 2037793; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Ciprofloxacin

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

CIPROFLOXACIN - HSDB

Supplemental Content

Save items

Related citations in PubMed

Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. [Am J Ophthalmol. 2004]
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC. Am J Ophthalmol. 2004 Mar; 137(3):453-8.
Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization. [Arch Intern Med. 1990]
Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
Peterson LR, Quick JN, Jensen B, Homann S, Johnson S, Tenquist J, Shanholtzer C, Petzel RA, Sinn L, Gerding DN. Arch Intern Med. 1990 Oct; 150(10):2151-5.
Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates. [J Clin Microbiol. 1992]
Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates.
Blumberg HM, Rimland D, Kiehlbauch JA, Terry PM, Wachsmuth IK. J Clin Microbiol. 1992 Feb; 30(2):362-9.
Review Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. [Curr Opin Infect Dis. 2003]
Review Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children.
Marcinak JF, Frank AL. Curr Opin Infect Dis. 2003 Jun; 16(3):265-9.
Review Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. [FEMS Immunol Med Microbiol. 2004]
Review Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones.
Aires de Sousa M, de Lencastre H. FEMS Immunol Med Microbiol. 2004 Mar 8; 40(2):101-11.

See reviews... See all...

Cited by 38 PubMed Central articles

Confronting antibiotic-resistant organisms - A Canadian perspective. [Can J Infect Dis. 1995]
Confronting antibiotic-resistant organisms - A Canadian perspective.
Conly J, Shafran S. Can J Infect Dis. 1995 May; 6(3):130-2.
Home iv antibiotic therapy through a medical day care unit. [Can J Infect Dis. 1993]
Home iv antibiotic therapy through a medical day care unit.
Gourdeau M, Deschênes L, Caron M, Desmarais M. Can J Infect Dis. 1993 May; 4(3):158-62.
Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections. [Antimicrob Agents Chemother. 2...]
Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.
Fernandez J, Hilliard JJ, Morrow BJ, Melton JL, Flamm RK, Barron AM, Lynch AS. Antimicrob Agents Chemother. 2011 Dec; 55(12):5522-8. Epub 2011 Sep 12.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -re...
Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.
J Infect Dis. 1991 Jun ;163(6):1279-85.

PubMed
Orally administered emu oil decreases acute inflammation and alters selected sma...
Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis.
Br J Nutr. 2010 Aug ;104(4):513-9. Epub 2010 Apr 9 .

PubMed
FTO variant rs9939609 is associated with body mass index and waist circumference...
FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European- and African-American youth.
BMC Med Genet. 2010 Apr 9 ;11:57.

PubMed
Zidovudine-associated embryonic toxicity in mice.
Zidovudine-associated embryonic toxicity in mice.
J Infect Dis. 1991 Jun ;163(6):1212-8.

PubMed
Comparison of selected canine vector-borne diseases between urban animal shelter...
Comparison of selected canine vector-borne diseases between urban animal shelter and rural hunting dogs in Korea.
Parasit Vectors. 2010 Apr 8 ;3(1):32.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: